AQUESTIVE THERAPEUTICS, INC.

AQST NASDAQ
4.280
+0.500
+13.23%
Opening 14:40 08/21 EDT
Open
3.830
Prev Close
3.780
High
4.315
Low
3.810
Volume
246.90K
Avg Vol (3M)
113.58K
52 Week High
20.70
52 Week Low
2.960
% Turnover
1.03%
Market Cap
102.72M
1D
5D
1M
3M
1Y
5Y

Related

Webull offers AQUESTIVE THERAPEUTICS, INC. AQST stock price, real time market quotes, professional analyst ratings, and in-depth charts, You can share investing ideas in community to communicate with others and learn trading skills.

Company Profile

Aquestive Therapeutics, Inc. is a specialty pharmaceutical company. The Company is focused on the development of treatments for diseases related to the central nervous system (CNS). Its CNS programs consist of a pipeline of products that include Libervant, Sympazan, and AQST-117. Libervant is a buccal soluble film formulation of diazepam for the treatment of recurrent epileptic seizures. Sympazan is an oral soluble film formulation of clobazam for the treatment of seizures associated with a rare, intractable form of epilepsy known as Lennox-Gastaut Syndrome. AQST-117 is an oral soluble film formulation of riluzole for the treatment of Amyotrophic Lateral Sclerosis. The Company’s complex molecule programs consist of AQST-108, and AQST-305, for the treatment of anaphylaxis and neuroendocrine tumors respectively. The Company also has a pipeline of products under partner programs, which includes Suboxone and APL-130277 for the treatment of opioid dependence, and Parkinson’s disease.
MORE >

Recently

Name
Price
%Change